Gerber Hans-Peter 4
4 · SUTRO BIOPHARMA, INC. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
Transactions
- Tax Payment
Common Stock
2025-03-01$1.59/sh−4,621$7,347→ 30,749 total - Exercise/Conversion
Common Stock
2025-03-01+11,250→ 35,370 total - Exercise/Conversion
Restricted Stock Units (RSUs)
2025-03-01−11,250→ 33,750 totalExp: 2028-03-01→ Common Stock (11,250 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.